发明授权
EP1427812B1 PRODUCTION OF CULTURED HUMAN MAST CELLS AND BASOPHILS FOR HIGH THROUGHPUT SMALL MOLECULE DRUG DISCOVERY
有权
生产培养的人肥大细胞和嗜碱性粒细胞高通量DISCOVERY小的药物分子
- 专利标题: PRODUCTION OF CULTURED HUMAN MAST CELLS AND BASOPHILS FOR HIGH THROUGHPUT SMALL MOLECULE DRUG DISCOVERY
- 专利标题(中): 生产培养的人肥大细胞和嗜碱性粒细胞高通量DISCOVERY小的药物分子
-
申请号: EP02763580.4申请日: 2002-08-29
-
公开(公告)号: EP1427812B1公开(公告)日: 2008-11-19
- 发明人: ROSSI, Alexander, B.
- 申请人: Rigel Pharmaceuticals, Inc.
- 申请人地址: 1180 Veterans Boulevard South San Francisco, CA 94080 US
- 专利权人: Rigel Pharmaceuticals, Inc.
- 当前专利权人: Rigel Pharmaceuticals, Inc.
- 当前专利权人地址: 1180 Veterans Boulevard South San Francisco, CA 94080 US
- 代理机构: Kiddle, Simon John
- 优先权: US316723P 20010831; US53355 20011108
- 国际公布: WO2003020896 20030313
- 主分类号: C12N5/02
- IPC分类号: C12N5/02 ; C12N5/08 ; C12N5/00
摘要:
Provided are methods for producing and screening proliferated populations of CD34-negative progenitor cells, mucosal mast cells, connective tissue-type mast cells and basophil cells. The methods generate uniform proliferated populations of cells. The proliferated populations contain a uniform population of a size suitable for use in high throughput screening methods, for example, screening for agents that alter exocytosis. The invention includes screening the proliferated populations with at least one candidate bioactive agent, and evaluating the cells to detect a cell with an altered phenotype. The invention also includes isolating a candidate bioactive agent that causes the altered phenotype. Additionally, cells formed according to the described methods are also encompassed by the invention.
公开/授权文献
信息查询